Drug class
Dietary Cholesterol Absorption Inhibitor; HMG-CoA Reductase Inhibitor
Mechanism of action
Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
General use cases
- Hypercholesterolemia
- Hyperlipoproteinemia Type II
- Hyperlipidemia, Familial Combined
- elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to other lipid-lowering treatments (e
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
